Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
43
datasets available to search
ShareScore release 0.9.0
Dataset results
43 results for “Gastroenteropancreatic Neuroendocrine”
To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
ClinicalTrials.gov study NCT03220217. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.
ClinicalTrials.gov study NCT03980925. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin
ClinicalTrials.gov study NCT03095274. IPD Sharing: NO. Countries: 1. Publications: 1.
Nanostring PanCancer IO360 Data of Gastroenteropancreatic High-Grade Neuroendocrine Carcinoma
<p>Zip file includes raw RCC files used by Nanostring for data visualization of genomic information along with links to the Nanostring website where this data can be viewed in graphical format. </p>
TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors
ClinicalTrials.gov study NCT03079440. IPD Sharing: NO. Countries: 1. Publications: 5.
Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors
ClinicalTrials.gov study NCT02078843. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients with an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment
ClinicalTrials.gov study NCT05255133. IPD Sharing: NO. Countries: 1. Publications: 1.
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
ClinicalTrials.gov study NCT03017690. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs)
ClinicalTrials.gov study NCT03591731. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)
ClinicalTrials.gov study NCT02248012. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
ClinicalTrials.gov study NCT06016855. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
ClinicalTrials.gov study NCT04524442. IPD Sharing: YES. Countries: 4. Publications: 0.
Nutrition in Gastroenteropancreatic Neuroendocrine Tumor
ClinicalTrials.gov study NCT04986085. IPD Sharing: NO. Countries: 1. Publications: 0.
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas
ClinicalTrials.gov study NCT03042780. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to testABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System
ClinicalTrials.gov study NCT03670030. IPD Sharing: NO. Countries: 1. Publications: 0.
Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver
ClinicalTrials.gov study NCT04544098. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors
ClinicalTrials.gov study NCT03043664. IPD Sharing: NO. Countries: 1. Publications: 0.
Integrated miRNAs profiling, DNA methylation, and RNA expression in gastroenteropancreatic neuroendocrine neoplasias [methylation]
GEO Series GSE211483. Homo sapiens. 40 samples. Type: Methylation profiling by genome tiling array.
microRNA profiling in different grading of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
GEO Series GSE135034. Homo sapiens. 18 samples. Type: Non-coding RNA profiling by array.
Integrated miRNAs profiling, DNA methylation, and RNA expression in gastroenteropancreatic neuroendocrine neoplasias [miRNA]
GEO Series GSE211482. Homo sapiens. 168 samples. Type: Expression profiling by RT-PCR; Non-coding RNA profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.